Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$802,092
+$276,480 QoQ
Shares Held
5,118
+48.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#697
of 1,603 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KINTRA WEALTH, LLC holds $28,644,092 across 11 Drug Manufacturers - General names. NVS ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
32,918 | $8,360,184 | |
| 2 | ABBV |
AbbVie Inc.
|
20,908 | $5,261,289 | |
| 3 | MRK |
Merck & Co., Inc.
|
37,050 | $4,760,925 | |
| 4 | LLY |
ELI LILLY & Co
|
3,108 | $3,727,828 | |
| 5 | AMGN |
Amgen Inc
|
6,605 | $2,391,802 | |
| 6 | PFE |
Pfizer Inc
|
56,271 | $1,355,005 | |
| 7 | NVS |
Novartis AG
This page
|
5,118 | $802,092 | |
| 8 | NVO |
Novo Nordisk A S
|
14,248 | $683,049 |
All Filings in NVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $802,092 | 5,118 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $525,612 | 3,441 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $379,280 | 2,751 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $324,190 | 2,528 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||